bobbybobby
FeatureMarketsStocks

CoStar Group

CSGP

$37.38

-3.59%

CoStar Group Inc. is a leading provider of commercial real estate data, analytics, and online marketplace platforms, operating within the Real Estate Services industry. The company is a dominant market leader, distinguished by its comprehensive database covering over 5 million properties and its portfolio of well-known brands like CoStar Suite, LoopNet, and Apartments.com, which generate predominantly subscription-based revenue. The current investor narrative is heavily focused on the company's aggressive international expansion into markets like Canada and Europe, juxtaposed against significant market skepticism regarding its profitability trajectory and high operating expenses, as evidenced by recent sharp stock price declines following earnings reports.…

Should I buy CSGP
Bobby Quantitative Model
Apr 23, 2026

CSGP

CoStar Group

$37.38

-3.59%
Apr 23, 2026
Bobby Quantitative Model
CoStar Group Inc. is a leading provider of commercial real estate data, analytics, and online marketplace platforms, operating within the Real Estate Services industry. The company is a dominant market leader, distinguished by its comprehensive database covering over 5 million properties and its portfolio of well-known brands like CoStar Suite, LoopNet, and Apartments.com, which generate predominantly subscription-based revenue. The current investor narrative is heavily focused on the company's aggressive international expansion into markets like Canada and Europe, juxtaposed against significant market skepticism regarding its profitability trajectory and high operating expenses, as evidenced by recent sharp stock price declines following earnings reports.
Should I buy CSGP

People also watch

CBRE Group

CBRE Group

CBRE

Analysis
Jones Lang LaSalle

Jones Lang LaSalle

JLL

Analysis
Opendoor

Opendoor

OPEN

Analysis
Welltower

Welltower

WELL

Analysis
Prologis

Prologis

PLD

Analysis

BobbyInvestment Opinion: Should I buy CSGP Today?

Rating: Hold. The core thesis is that CoStar is a high-quality franchise caught in a painful transition, where aggressive investment is masking underlying profitability, but the stock's severe de-rating has balanced the risk/reward, warranting patience rather than new investment.

Supporting evidence includes a robust revenue growth rate of 26.87% YoY, a dominant market position, and a strong balance sheet (D/E 0.14). However, valuation sends mixed signals: the trailing PS of 8.6x is at a deep discount to its own history (from >40x), suggesting value, but the forward P/E of 22.3x and P/CF of 65.2x imply high expectations for a profit recovery that has not yet occurred. Analyst sentiment is mixed with no clear catalyst, and the stock trades just 14.3% above its 52-week low, indicating the market has already priced in significant negativity.

The thesis would upgrade to a Buy if the company demonstrates sequential operating margin expansion for two consecutive quarters, signaling expense control, or if the stock falls below $35, offering a greater margin of safety. It would downgrade to a Sell if revenue growth decelerates below 15% YoY or if operating margins fail to turn positive by year-end 2026. Relative to its own history, the stock is undervalued, but relative to the high profitability expectations embedded in its forward multiple, it appears fairly valued to slightly overvalued until proof of execution emerges.

Sign up to view all

CSGP 12-Month Price Forecast

CoStar presents a classic 'show me' story. The investment case hinges on a transition from revenue growth to profit growth, a transition that has been promised but not delivered. The severe price decline has mitigated valuation risk, but the stock lacks a catalyst for a sustained recovery without concrete evidence of operating leverage. The stance is neutral with medium confidence, as the outcome is binary and data-dependent. We would upgrade to bullish on evidence of sustained margin expansion (e.g., two consecutive quarters of positive operating income growth). We would downgrade to bearish on any material deceleration in top-line growth below 15%.

Historical Price
Current Price $37.38
Average Target $50
High Target $75
Low Target $30

Wall Street consensus

Most Wall Street analysts maintain a constructive view on CoStar Group's 12-month outlook, with a consensus price target around $48.59 and implied upside of +30.0% versus the current price.

Average Target

$48.59

6 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

6

covering this stock

Price Range

$30 - $49

Analyst target range

Buy
1 (17%)
Hold
3 (50%)
Sell
2 (33%)

Analyst coverage is limited, with only 5 analysts providing estimates, indicating this large-cap stock has surprisingly sparse institutional research coverage which can contribute to higher volatility. The consensus sentiment, inferred from recent institutional ratings, is mixed but leans cautiously optimistic, with firms like Goldman Sachs, BTIG, and Needham maintaining 'Buy' or equivalent ratings, while Wells Fargo is 'Underweight' and RBC and BMO are at 'Sector Perform' or 'Market Perform'. The average revenue estimate for the period is approximately $6.49 billion, but a specific consensus price target and implied upside are not available in the provided data. The range of analyst actions shows no recent downgrades from the provided sample, with the latest actions in February and March 2026 largely reiterating existing ratings, suggesting analysts are in a 'wait-and-see' mode post-earnings. The wide dispersion in ratings—from Buy to Underweight—signals high uncertainty and debate regarding the company's near-term trajectory and the sustainability of its investment thesis, particularly around profitability. This lack of strong, upwardly revised conviction, coupled with the low number of covering analysts, implies that the stock lacks a clear near-term catalyst and must prove its fundamentals to attract broader institutional support.

Drowning in data?

Find the real signal!

Chat Now

Drowning in data?

Find the real signal!

Chat Now

Bulls vs Bears: CSGP Investment Factors

The evidence currently tilts bearish, as the company's severe profitability issues and relentless stock price decline outweigh its strong market position and revenue growth. The most critical tension in the investment debate is whether CoStar's massive operating expense investment (evidenced by $507M in Q4 SGA) will ultimately translate into sustainable operating leverage and consistent profits, or if it represents a permanent drag on shareholder returns. The bear case is supported by current negative operating margins and price action, while the bull case hinges entirely on a future inflection in profitability that has yet to materialize.

Bullish

  • Dominant Market Position: CoStar is the leading provider of commercial real estate data with a database covering over 5 million properties and a portfolio of essential brands like CoStar Suite and Apartments.com. This entrenched position, generating over 75% subscription-based revenue, provides a durable competitive moat and a foundation for sustained growth.
  • Strong Top-Line Growth: Q4 2025 revenue grew 26.87% year-over-year to $900 million, demonstrating robust demand for its services despite market skepticism. Sequential quarterly revenue increased from $732.2M to $900M, indicating continued business momentum.
  • Healthy Gross Margins: The company maintains a strong gross margin of 73.89% (Q4 2025) and a trailing gross margin of 75.24%, indicating its core data and marketplace offerings are highly profitable. This provides a solid foundation for potential operating leverage if expense growth is controlled.
  • Clean Balance Sheet: With a low debt-to-equity ratio of 0.14 and a strong current ratio of 2.84, CoStar has minimal financial risk and ample liquidity to fund its international expansion without balance sheet strain.

Bearish

  • Erratic & Negative Profitability: Profitability is highly inconsistent, with the company swinging from a Q1 2025 net loss of $14.8M to Q4 2025 net income of $47M. The trailing operating margin is negative at -2.22%, and Return on Equity is a negligible 0.084%, signaling severe inefficiency.
  • Runaway Operating Expenses: Sky-high SGA expenses, reaching $507M in Q4 2025, are eroding strong gross profits. This spending, driven by aggressive international expansion and sales/marketing, has prevented operating leverage and caused investor alarm, as evidenced by sharp post-earnings sell-offs.
  • Persistent Technical Downtrend: The stock is in a severe downtrend, down 50.16% over the past year and 39.21% over the last three months. It trades just 14.3% above its 52-week low of $34.75, indicating sustained selling pressure and a lack of bullish catalysts.
  • Weak Cash Flow Generation: Trailing twelve-month Free Cash Flow is only $117.3M, yielding a paltry FCF yield relative to its $28B market cap. The Price-to-Cash Flow ratio of 65.2x is exorbitant, highlighting poor cash conversion from revenue.

CSGP Technical Analysis

The prevailing price trend is a severe and sustained downtrend, with the stock down 50.16% over the past year. The current price of $39.72 sits just 14.3% above its 52-week low of $34.75, positioning it in the deep value/oversold territory of its annual range, which also suggests it is far from any technical recovery and remains under heavy selling pressure. Recent momentum shows no signs of abatement, with the stock down 39.21% over the last three months and a further 7.86% decline over the past month, indicating selling pressure is persistent and accelerating relative to the longer-term downtrend. This consistent negative momentum across all timeframes signals strong bearish conviction, with a beta of 0.92 indicating the stock's decline is largely idiosyncratic and not simply tracking a weak broader market, which was up 34.9% over the same one-year period. Key technical levels are clearly defined, with immediate support at the 52-week low of $34.75 and formidable resistance far above at the 52-week high of $97.43. A breakdown below the $34.75 support level would signal a continuation of the bear market and likely trigger another wave of selling, while any recovery would need to overcome a massive wall of overhead supply. The stock's maximum drawdown of -62.33% and a short ratio of 3.78 highlight extreme volatility and significant bearish speculative positioning, which can exacerbate both downside moves and potential short-covering rallies, though the latter appears absent given the ongoing price erosion.

Beta

0.92

0.92x market volatility

Max Drawdown

-62.3%

Largest decline past year

52-Week Range

$35-$97

Price range past year

Annual Return

-54.3%

Cumulative gain past year

PeriodCSGP ReturnS&P 500
1m-9.8%+8.5%
3m-43.0%+2.8%
6m-52.0%+4.6%
1y-54.3%+32.3%
ytd-43.1%+3.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now

CSGP Fundamental Analysis

Revenue growth remains robust on a year-over-year basis, with Q4 2025 revenue of $900 million representing a 26.87% increase from the prior year's quarter. However, the multi-quarter trend reveals volatility in profitability, as sequential revenue grew from $732.2 million in Q1 2025 to the $900 million peak in Q4, but this was accompanied by wildly fluctuating bottom-line results. Segment data indicates the Multifamily Online Marketplace ($303 million) and the core CoStar Suite ($277 million) are the primary revenue drivers, underscoring the company's dual focus on data subscriptions and transaction-based marketplaces. Profitability is highly inconsistent and a major concern, with the company swinging from a net loss of $14.8 million in Q1 2025 to a net income of $47 million in Q4 2025, while gross margin remained healthy at 73.89% in the latest quarter. The operating margin was negative at -2.22% for the trailing period, indicating that despite strong gross margins of 75.24%, soaring sales, general & administrative (SGA) and R&D expenses—evidenced by $507 million in SGA alone in Q4—are severely compressing operating profits and leading to erratic earnings, a trend that alarms investors expecting leverage from scale. The balance sheet is a relative strength, with a solid current ratio of 2.84 and a low debt-to-equity ratio of 0.14, indicating minimal financial risk from leverage. However, cash flow generation is weak relative to the market cap; trailing twelve-month free cash flow is only $117.3 million, yielding a paltry FCF yield, and the latest quarterly operating cash flow was $162.1 million against significant capital expenditures. The return on equity is virtually nonexistent at 0.084%, highlighting profound inefficiency in generating profits from shareholder equity, which calls into question the quality of earnings when they do appear.

Quarterly Revenue

$900000000.0B

2025-12

Revenue YoY Growth

+0.26%

YoY Comparison

Gross Margin

+0.73%

Latest Quarter

Free Cash Flow

$117300000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

CoStar Suite
Information services
LoopNet
Multifamily Online Marketplace
Residential

Open an Account, get $2 TSLA now!

Open Account Now

Open an Account, get $2 TSLA now!

Open Account Now

Valuation Analysis: Is CSGP Overvalued?

Given the company's minimal and erratic net income, the trailing P/E ratio of approximately 4003x is meaningless; therefore, the Price-to-Sales (PS) ratio is the primary valuation metric. CoStar trades at a trailing PS ratio of 8.63x and an Enterprise Value-to-Sales (EV/Sales) of 5.04x. The forward PE of 22.3x, based on analyst EPS estimates, suggests the market is pricing in a significant recovery in profitability, but the massive gap between trailing and forward multiples underscores extreme uncertainty and high expectations embedded in the current price. Compared to industry averages, specific data is not available in the provided dataset, but a PS ratio of 8.6x for a subscription-based data and marketplace company is not exorbitant if sustained high growth and margin expansion were assured. The current valuation discount relative to its own historical norms is severe; for instance, the stock's PS ratio has collapsed from levels above 40x seen in recent quarters (e.g., 42.5x in Q3 2025) to the current 8.6x. This dramatic de-rating to near the bottom of its historical valuation band reflects the market's punitive reassessment of its growth durability and profit potential, presenting a value opportunity only if the fundamental issues are resolved. The historical context is stark: the stock's own valuation has compressed dramatically, with the PS ratio falling from over 40x to 8.6x. Trading near the bottom of its historical valuation range suggests the market is pricing in significant fundamental deterioration or a permanent impairment of growth prospects. For the stock to re-rate higher, CoStar must demonstrate a clear and sustainable path to expanding operating margins and generating consistent free cash flow, which the recent financials have failed to show.

PE

4003.7x

Latest Quarter

vs. Historical

High-End

5-Year PE Range -549x~1430x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

100.9x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are centered on profitability and cash flow. Despite 27% YoY revenue growth, operating margins are negative (-2.22%) due to soaring SGA expenses ($507M in Q4). Net income is wildly erratic, swinging from a $14.8M loss to a $47M profit within a year, and free cash flow generation is weak at $117.3M TTM. The company's return metrics are abysmal, with an ROE of 0.084%, indicating it is failing to generate profits from shareholder equity. The primary risk is that high growth spending continues indefinitely without delivering operating leverage, making the forward P/E of 22.3x unjustifiable.

Market & Competitive Risks include severe valuation compression and idiosyncratic underperformance. The stock's PS ratio has collapsed from over 40x to 8.6x, reflecting a punitive market reassessment of its growth durability. With a beta of 0.92, its 50% annual decline is largely company-specific, not market-driven (SPY up 34.9%). The high short ratio of 3.78 indicates significant speculative bearish positioning, which can exacerbate downside moves. The lack of a dividend and sparse analyst coverage (only 5 analysts) contribute to volatility and reduce institutional support, leaving the stock vulnerable to further de-rating if growth decelerates.

Worst-Case Scenario involves a failure to curb expense growth leading to sustained operating losses, triggering a wave of analyst downgrades and a loss of investor confidence. This could cause the stock to break below its key technical support at the 52-week low of $34.75 and re-test levels implied by its maximum drawdown of -62.33%. A realistic downside from the current price of $39.72 could be a decline of 25-30%, towards the $28-$30 range, as the market prices in a prolonged period of no earnings growth and a further compression of the PS multiple towards 6x. The chain of events would be: Q2 2026 earnings miss on profitability, guidance reduction for operating margins, followed by multiple rating downgrades from the current mixed analyst pool.

FAQ

The key risks are, in order of severity: 1) Profitability Risk: The inability to convert high revenue growth into consistent profits, with operating margins at -2.22% and wildly swinging quarterly net income. 2) Expense Control Risk: Runaway SGA expenses ($507M in Q4) that may not decline, preventing operating leverage. 3) Valuation Compression Risk: The forward P/E of 22.3x could compress further if earnings estimates are cut, continuing the stock's severe downtrend. 4) Execution & Competitive Risk: Potential stumbles in its costly international expansion or increased competition eroding its core data subscription moat.

The 12-month forecast for CSGP is highly bifurcated, with three scenarios. The Base Case (50% probability) sees the stock trading between $45 and $55, as growth continues but profitability remains elusive, leading to range-bound action. The Bull Case (25% probability) projects a rally to $60-$75 on successful margin expansion and a valuation re-rating. The Bear Case (25% probability) warns of a decline to $30-$40 if profitability worsens and the stock breaks key support. The base case is most likely, contingent on the assumption that the company meets revenue estimates but fails to significantly improve margins, leaving investors in a 'wait-and-see' mode.

CSGP's valuation presents a paradox. Relative to its own history, it is deeply undervalued, with its Price-to-Sales ratio of 8.63x representing a dramatic de-rating from levels above 40x. However, based on profitability, it appears overvalued, with a trailing P/E of ~4003x and a high Price-to-Cash Flow of 65.2x. The forward P/E of 22.3x suggests the market is paying a premium for expected future earnings growth that has not yet materialized. Overall, the stock is fairly valued to slightly overvalued relative to its current financial profile but undervalued relative to its long-term potential if management executes successfully.

CSGP is a high-risk, high-potential-reward stock that is not a clear-cut 'good buy' for most investors at this moment. For aggressive investors who believe the company will soon achieve operating leverage, the severe 50% price decline and PS ratio at 8.6x (down from >40x) may represent a compelling entry point. However, the stock carries significant risk, as evidenced by its negative operating margin, erratic profits, and lack of a near-term catalyst. It could be a good buy for a patient, long-term holder with conviction in the business model, but it is a speculative Hold, not a core portfolio Buy, until profitability trends improve.

CSGP is unsuitable for short-term trading due to its high volatility (beta 0.92, max drawdown -62.33%), lack of dividends, and absence of a clear near-term catalyst. It is a long-term investment proposition, requiring a minimum horizon of 3-5 years to allow management's growth investments to potentially mature into sustainable profitability. The stock's thesis is based on a multi-year transition to leverage, making it appropriate only for patient capital willing to endure significant price fluctuations. Day traders or swing traders should avoid it given the persistent downtrend and high short interest.

People also watch

CBRE Group

CBRE Group

CBRE

Analysis
Jones Lang LaSalle

Jones Lang LaSalle

JLL

Analysis
Opendoor

Opendoor

OPEN

Analysis
Welltower

Welltower

WELL

Analysis
Prologis

Prologis

PLD

Analysis

Product

Partner

Markets

Stocks

© 2026 Flow AI Limited. All Rights Reserved.

Bobby, the world's first financial AI Agent, is developed by Flow AI, an AI-driven company. Flow AI is dedicated to providing global investors with AI-powered financial services across multiple markets.

Bobby
Bobby AI
RockFlow Platform
Stock Event
Macro Event
Industry Event
NVDA
AAPL
MSFT
AMZN
GOOG
META
TSLA
Privacy Policy
Terms of Use